Xeris Biopharma Holdings, Inc. (XERS)

2.11
0.07 3.20
NASDAQ
Prev Close 2.18
Open 2.02
Day Low/High 1.96 / 2.13
52 Wk Low/High 1.77 / 7.94
Volume 2.70M
Exchange NASDAQ
Shares Outstanding 124.71B
Market Cap 280.60M
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

10 Stocks I'm Watching in 2022, an Update

10 Stocks I'm Watching in 2022, an Update

Here's a follow-up on stocks that are on my radar this year -- and why I'm still tracking them, despite moving lower.

How I'm Handling and Trading the Market's Rotational Action

How I'm Handling and Trading the Market's Rotational Action

The most significant difficulty is that it undermines stock-picking.

This Market Action Is Very Tricky

This Market Action Is Very Tricky

It's clearly a stock picker's environment.

Small-Caps Waiting to Be Discovered in 2022 (Part 2)

Small-Caps Waiting to Be Discovered in 2022 (Part 2)

There's an unusually large number of attractive small-caps in the market right now that have been hidden under the action of the indexes.

It's a Stock Pickers Market

It's a Stock Pickers Market

There's much going on with individual stocks, and I like this trading action.

Secondary Names Get a Look as Rotation Takes Place

Secondary Names Get a Look as Rotation Takes Place

Traders continue to hunt for good action as the gap narrows between extended big-cap stocks and beat-down smaller names.

I Have 14 Key Stocks on My Shopping List

I Have 14 Key Stocks on My Shopping List

My positions change very fast and I'm actively trading all these names.

There's Good News for 3 Biotech Names

There's Good News for 3 Biotech Names

And It comes after one of the best days of the year for the biotech sector.

Traders Hit the Buy Button: Here's What I'm Watching

Traders Hit the Buy Button: Here's What I'm Watching

Many of the stocks favored by speculative traders are coming on strong.

Is This the Start of a Long-Awaited Rebound for Biotech?

Is This the Start of a Long-Awaited Rebound for Biotech?

Life has not been easy for the small-cap biotech investor so far in 2021.

The Time to Shed Dead Weight Is Probably Now

The Time to Shed Dead Weight Is Probably Now

To get a clearer view of where your holdings are headed amid this torturous action, consider cutting bait with a stock, even if you don't agree with the price action.

10 Beaten-Down Favorites I'm Buying as Smaller Stocks Bounce

10 Beaten-Down Favorites I'm Buying as Smaller Stocks Bounce

There are any number of ways the inconsistency in the market action can fix itself.

3 Buys I Made as the Trading Environment Improves

3 Buys I Made as the Trading Environment Improves

I'm becoming more confident that small-caps have bottomed heading into earnings.

Stock Picking Remains the Name of the Game

Stock Picking Remains the Name of the Game

The tricky part is that sector strength is shifting fast.

A Little Rest Friday Is Exactly What's Needed to Keep the Indices Running Higher

A Little Rest Friday Is Exactly What's Needed to Keep the Indices Running Higher

This is a nice-looking uptrend right now, and I see no reason to start anticipating major problems.

Here Are 5 Small-Cap Stocks That I'm Trading Now

Here Are 5 Small-Cap Stocks That I'm Trading Now

We have some healthy action out there, and charts are developing well.

This Market Action Is Messy

This Market Action Is Messy

The broader market is struggling with some concerns again about inflation and the possibility of a less dovish Fed.

Opening the Biotech Mailbag to Find Big News About a Trio of Stocks

Opening the Biotech Mailbag to Find Big News About a Trio of Stocks

There's a merger involving one company, a collaborative agreement for another and hints of a positive regulatory development for a third.

Long-Suffering Biotech May Be Hitting a Bottom

Long-Suffering Biotech May Be Hitting a Bottom

Here are some biotech and gaming names I am watching as these sectors begin to rotate.

How to Bottom Fish

How to Bottom Fish

Here's my three-point guide -- with a focus on the biotechs.

Making the Best of the Peculiar Market Action

Making the Best of the Peculiar Market Action

Trading in biotech stocks and a particular SPAC play are on my mind.

16 Biotechs I Like Even as a Lack of Liquidity Is Hurting the Market

16 Biotechs I Like Even as a Lack of Liquidity Is Hurting the Market

Quite a few stocks are fading right now -- not due to poor fundamentals, but due to lack of buying interest.

The Dominant Trading Theme Right Now Is 'Waiting for the Next Catalyst'

The Dominant Trading Theme Right Now Is 'Waiting for the Next Catalyst'

I'm currently heavily invested in several stocks that are drifting around as I'm quite confident that the eventual catalysts will come.

As End of the Quarter Pressures Relent, Stock Picking Picks Up

As End of the Quarter Pressures Relent, Stock Picking Picks Up

So far today, aggressive stock picking is looking like a possibility.

Rotation Reverses as 'Reopen' Plays Are Hit

Rotation Reverses as 'Reopen' Plays Are Hit

The big cap technology names are doing much better.

The Bulls Are Back in Town: 20 Stocks I'm Trading

The Bulls Are Back in Town: 20 Stocks I'm Trading

There is so much going on right now that it is overwhelming.

17 Stocks on My Shopping List

17 Stocks on My Shopping List

All these names, I believe, have potential positive catalysts, but they all can drift lower in a poor market.

I've Been a Buyer Friday, Making Partial Buys Like I Always Do

I've Been a Buyer Friday, Making Partial Buys Like I Always Do

It's premature to predict that a low has been made, but plenty of stocks are quite washed-out already and are starting to find support.